Table 1.

Demographic and clinical details of the non-SCC group

Sex	Age	Histology	TNM	Treatment	Recurrence treatment	Last follow-up (m)	Status
M	60	Chondrosarcoma	cT2 N0 M0	CTRA	TLM (5 m)	6	AWD
M	51	Chondrosarcoma	cT4a N0 M0	CTRA	CTRA (77 m); TL (132 m)	200	NED
F	41	Solitary fibrous tumor	cT2 N0 M0	PPL	–	58	NED
F	68	Sinovial sarcoma	cT2 N0 M0	PPL	–	18	NED
M	63	Rhabdomyosarcoma	cT2 N0 M0	TLM	–	42	NED
M	67	Chondrosarcoma	cT3 N0 M0	TLM	TL (4 m)	89	NED
M	66	Solitary fibrous tumor	cT2 N0 M0	TLM	PPL (6 m)	55	NED
M	74	Liposarcoma	cT2 N0 M0	TLM	TLM (12 m)	29	DOC
F	78	Kaposi’s sarcoma	cT2 N0 M0	TLM	–	40	NED
M	54	Malignant peripheral nerve sheat tumor	cT4a N0 M0	PPL	–	20	NED
M	67	Pleomorphic sarcoma	cT1 N0 M0	TLM	–	19	NED
F	63	Adenoid cystic carcinoma	cT3 N0 M0	TLM	TL (1 m)	57	NED
F	65	Chondrosarcoma	cT3 N0 M0	Laryngofissure	-	7	NED
M	67	Adenoid cystic carcinoma	cT4a N0 M0	OPHL	TL (28 m)	29	NED
M	72	Small cell neuroendocrine carcinoma	cT1a N0 M0	TLM	–	29	NED
M	64	Liposarcoma	cT2 N0 M0	TLM	PPL (50 m)	92	AWD
F	66	Small cell neuroendocrine carcinoma	cT4a N0 M0	RT-CHT	CHT (5 m)	77	DOD
M	67	Chondrosarcoma	cT1 N0 M0	TLM	–	39	NED
M	71	Chondrosarcoma	cT1 N0 M0	TLM	PPL (7 m)	61	NED
F	66	Chondrosarcoma	cT2 N0 M0	TLM	TLM (2 m)	14	AWD
F	74	Chondrosarcoma	cT3 N0 M0	TLM	–	1	NED

Legend: M male; F female; TLM transoral laser microsurgery; CTRA crico-tracheal resection and anastomosis; OPHL open partial horizontal laryngectomy; TL total laryngectomy; PPL partial pharyngo-laryngectomy; RT radiotherapy; CHT chemotherapy; m months; AWD alive with disease; NED not evidence of disease; DOC dead of other causes; DOD dead of disease